Retron directed gene editing
AssigneeEnceladus Bio, Inc.
InventorsBrian Busser, Johann Neil Reshan Cooke, Robin L. Armstrong, Gregory Mazo, Glenn Christopher Tan, Madyson Scherr
Life of this patent
Estimating the term…
Abstract
Compounds, polypeptides, compositions, and nucleic acid molecules are provided herein that can be used, for example, to edit the genome of a cell, such as a human cell.
Claims63
A method of modifying, or inducing one or more sequence modifications in one or more target nucleic acids of interest at one or more target loci within a genome of a host cell, such as a mammalian cell, the method comprising:
- (a) transforming the host cell with one or more vectors encoding a heterologous nucleic acid molecule and a guide RNA (gRNA), wherein the heterologous nucleic acid molecule comprises a first inverted repeat nucleic acid molecule sequence upstream of a coding region and a second inverted repeat nucleic acid molecule sequence downstream of the coding region, wherein the coding region comprises a nucleic acid molecule comprising:
- (i) an msr locus and an msd locus comprising the nucleic acid sequence having at least 50%, at least 55%, at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, or at least 99% sequence identity to any one of SEQ ID NO:
- 1, or 2;
- and
- (ii) a donor DNA sequence within the msd locus,
- wherein the msr locus and the msd locus form a RT binding region;
- and
- (b) culturing the host cell or transformed progeny of the host cell under conditions sufficient for expressing from the one or more vectors the heterologous nucleic acid molecule comprising a retron transcript and a gRNA molecule to induce one or more sequence modifications in one or more target nucleic acids of interest at the one or more target loci within the genome.
A retron-guide RNA (gRNA) cassette comprising:
- a retron comprising:
- a first inverted repeat sequence coding region;
- an msr locus and an msd locus;
- a donor DNA sequence within the msd locus;
- and
- a second inverted repeat sequence coding region;
- and
- optionally a gRNA coding region,
- wherein the msr locus and the msd locus comprise the nucleic acid sequence having at least 50%, at least 55%, at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, or at least 99% sequence identity to any one of SEQ ID NO:
- 1, or 2.
A polypeptide having the formula of:
- of (N1)q-C1-L1-(N2)qq-R1-(N3)qqq, wherein C1 is a nuclease, L1 is a peptide linker, R1 is a RT protein, and N1 and N2 are each independently, a NLS sequence, and wherein q, qq, or qqq, are each independently, 0, 1, 2, or 3.
A polypeptide comprising a SSAP, RT, and a nuclease, wherein:
- the C-terminus of the RT is linked to the N-terminus of the nuclease, and the C-terminus of the nuclease is linked to the N-terminus of the SSAP;
- or
- the N-terminus of the RT is linked to the C-terminus of the nuclease, and the N-terminus of the nuclease is linked to the C-terminus of the SSAP.
Dependencies are inferred from the claim text.